Drugs for BPH May Delay Diagnosis of Prostate Cancer

Benign prostatic hypertrophy (BPH) is a very common condition in older men, affecting about 50% of men between the ages of 51 and 60. In men older than age 80, the prevalence may increase to as high as 90 percent....

3 Recent Safety-Related Medication Labeling Changes

When a medication becomes FDA approved and is used in a diverse patient population, previously unreported adverse effects often emerge. This is commonly due to the fact that clinical trials are conducted in...

Safety Review: Fluoroquinolone

Fluoroquinolones have been enormously popular and successful antibiotics, thanks to their broad antimicrobial spectra, convenient dosing and tissue penetration. The most recent CDC data reported nearly 30 million...

Request a demo of Charlie

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.